BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 22835281)

  • 1. New insights into the genetics of immune responses in rheumatoid arthritis.
    Ruyssen-Witrand A; Constantin A; Cambon-Thomsen A; Thomsen M
    Tissue Antigens; 2012 Aug; 80(2):105-18. PubMed ID: 22835281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
    Lundberg K; Bengtsson C; Kharlamova N; Reed E; Jiang X; Kallberg H; Pollak-Dorocic I; Israelsson L; Kessel C; Padyukov L; Holmdahl R; Alfredsson L; Klareskog L
    Ann Rheum Dis; 2013 May; 72(5):652-8. PubMed ID: 22661643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis.
    Szodoray P; Szabó Z; Kapitány A; Gyetvai A; Lakos G; Szántó S; Szücs G; Szekanecz Z
    Autoimmun Rev; 2010 Jan; 9(3):140-3. PubMed ID: 19427413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.
    Nordang GB; Flåm ST; Maehlen MT; Kvien TK; Viken MK; Lie BA
    Rheumatology (Oxford); 2013 Nov; 52(11):1973-82. PubMed ID: 23901134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.
    Laki J; Lundström E; Snir O; Rönnelid J; Ganji I; Catrina AI; Bengtsson C; Saevarsdottir S; Wick MC; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2012 Jul; 64(7):2078-84. PubMed ID: 22307773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis.
    Jiang X; Källberg H; Chen Z; Ärlestig L; Rantapää-Dahlqvist S; Davila S; Klareskog L; Padyukov L; Alfredsson L
    Rheumatology (Oxford); 2016 Jan; 55(1):149-55. PubMed ID: 26272072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to citrullinated proteins in rheumatoid arthritis.
    Klareskog L; Rönnelid J; Lundberg K; Padyukov L; Alfredsson L
    Annu Rev Immunol; 2008; 26():651-75. PubMed ID: 18173373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particular association of clinical and genetic features with autoimmunity to citrullinated α-enolase in rheumatoid arthritis.
    Montes A; Dieguez-Gonzalez R; Perez-Pampin E; Calaza M; Mera-Varela A; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2011 Mar; 63(3):654-61. PubMed ID: 21360494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
    Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
    Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of autoantibodies against citrullinated antigens/peptides by human B cells.
    Bellatin MF; Han M; Fallena M; Fan L; Xia D; Olsen N; Branch V; Karp D; Stastny P
    J Immunol; 2012 Apr; 188(7):3542-50. PubMed ID: 22345652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
    Luban S; Li ZG
    Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis.
    Wegner N; Lundberg K; Kinloch A; Fisher B; Malmström V; Feldmann M; Venables PJ
    Immunol Rev; 2010 Jan; 233(1):34-54. PubMed ID: 20192991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis.
    Toes RE; van der Woude D
    Acta Reumatol Port; 2011; 36(3):205-7. PubMed ID: 22113596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for increased susceptibility of Indigenous North Americans to seropositive rheumatoid arthritis.
    Scally SW; Law SC; Ting YT; Heemst JV; Sokolove J; Deutsch AJ; Bridie Clemens E; Moustakas AK; Papadopoulos GK; van der Woude D; Smolik I; Hitchon CA; Robinson DB; Ferucci ED; Bernstein CN; Meng X; Anaparti V; Huizinga T; Kedzierska K; Reid HH; Raychaudhuri S; Toes RE; Rossjohn J; El-Gabalawy H; Thomas R
    Ann Rheum Dis; 2017 Nov; 76(11):1915-1923. PubMed ID: 28801345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to citrullinated proteins: molecular interactions and arthritogenicity.
    Uysal H; Nandakumar KS; Kessel C; Haag S; Carlsen S; Burkhardt H; Holmdahl R
    Immunol Rev; 2010 Jan; 233(1):9-33. PubMed ID: 20192990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides.
    Bossini-Castillo L; de Kovel C; Kallberg H; van 't Slot R; Italiaander A; Coenen M; Tak PP; Posthumus MD; Wijmenga C; Huizinga T; van der Helm-van Mil AH; Stoeken-Rijsbergen G; Rodriguez-Rodriguez L; Balsa A; González-Álvaro I; González-Gay MÁ; Gómez-Vaquero C; Franke B; ; Vermeulen S; van der Horst-Bruinsma Ie; Dijkmans BA; Wolbink GJ; Ophoff RA; Maehlen MT; van Riel P; Merriman M; Klareskog L; Lie BA; Merriman T; Crusius JB; Brouwer E; Martin J; de Vries N; Toes R; Padyukov L; Koeleman BP
    Ann Rheum Dis; 2015 Mar; 74(3):e15. PubMed ID: 24532677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
    van der Woude D; Lie BA; Lundström E; Balsa A; Feitsma AL; Houwing-Duistermaat JJ; Verduijn W; Nordang GB; Alfredsson L; Klareskog L; Pascual-Salcedo D; Gonzalez-Gay MA; Lopez-Nevot MA; Valero F; Roep BO; Huizinga TW; Kvien TK; Martín J; Padyukov L; de Vries RR; Toes RE
    Arthritis Rheum; 2010 May; 62(5):1236-45. PubMed ID: 20131291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects.
    Terao C; Ohmura K; Kochi Y; Ikari K; Maruya E; Katayama M; Shimada K; Murasawa A; Honjo S; Takasugi K; Matsuo K; Tajima K; Suzuki A; Yamamoto K; Momohara S; Yamanaka H; Yamada R; Saji H; Matsuda F; Mimori T
    Ann Rheum Dis; 2011 Dec; 70(12):2134-9. PubMed ID: 21873689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is rheumatoid arthritis without anti-citrullinated peptide antibody a genetically distinct subset?].
    Ohmura K
    Nihon Rinsho Meneki Gakkai Kaishi; 2009 Dec; 32(6):484-91. PubMed ID: 20046016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.